Published: May, 2018

The global hepatitis E diagnostic tests market is characterized by an intense level of competition. The strongholds of the leading players coupled with the strategic efforts of the emerging players have been the key reasons behind the cutthroat competition. Furthermore, a major share of the market was held by Beijing Wantai Biological Pharmacy in 2015, and the company is expected to stay ahead of other players over the forthcoming years. The market players that follow Beijing Wantai Biological Pharmacy in terms of market share are also expected to resort to innovative business strategies to retain their streak of excellence. Strategic alliances are projected to be amongst the key highlights of the global market as several players aim to thrive by partnering with other market vendors. Moreover, the local and regional players are anticipated to concentrate on strengthening their reigns in their respective regions. In order to penetrate into the regional market, the international players are expected to resort to mergers and acquisitions. Besides this, pricing strategy has been a decisive element of the competitive landscape and is expected to keep influencing the dynamics of the market over the coming years. Some of the leading players in the global market for hepatitis E diagnostic tests are Primerdesign Ltd., Fortress Diagnostics Ltd., MP Biomedicals LLC, and Hoffmann-La Roche Ltd.

A report published by Transparency Market Research (TMR) deconstructs the elements of the global market for hepatitis E diagnostic tests. The global market is expected to cumulate a revenue of US$60.4 mn by 2024 escalating from a value of  US$43.7 mn in 2015. Furthermore, the CAGR of the global hepatitis E diagnostic market is expected to settle at 3.80% over the period between 2016 and 2024. Based on the type of test, ELISA HEV IgM tests have emerged as the most popular category of tests for the detection of Hepatitis E.

hepatitis e diagnostic tests market

Medical Awareness Campaigns to Drive Demand

Until a decade back, a large number of third-world countries were deprived of several vaccinations, treatments, and medical tests. However, in recent times, due to the efforts of the World Health Organization (WHO) and other healthcare bodies, the people within these countries now have access to better healthcare facilities. This has underhandedly contributed to the growth of the global market for hepatitis E and has created growth spaces for market players. Furthermore, the high incidence of hepatitis E across countries such as Uganda, Kenya, Nigeria, and Morocco has persuaded international bodies to institute better treatment facilities. Despite the affluent growth of the global market for hepatitis E treatment, the high incidence of asymptomatic diseases that cannot be easily diagnosed has hampered market growth.

Asia Pacific to Emerge as Leading Regional Segment

The endemicity of hepatitis E across countries such as Bangladesh, Nepal, Pakistan, Kazakhstan, Bhutan, Thailand, and Vietnam has given potency to the market for hepatitis E across Asia Pacific. Moreover, the efforts of the governments across these countries to offer better healthcare facilities have also fortified the growth of the global market. Furthermore, the market for hepatitis E in North America and Europe has also treaded a positive growth path over the past years.

The review is based on TMR’s report titled, “Hepatitis E Diagnostic Tests Market (Test Type - ELISA HEV IgM Test kits, ELISA HEV IgG Test Kits, and RT-PCR Test Kits; End User - Hospitals, Diagnostic Laboratories, Research Centers, and Point of Care) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 – 2024”

The Hepatitis E Diagnostic Tests Market has been segmented as follows:

 By Test Type

  • ELISA HEV IgM Test kits
  • ELISA HEV IgG Test kits
  • RT-PCR Test kits
  • Others 

By End User

  • Hospitals
  • Research Centers
  • Diagnostic Laboratories
  • Point of Care 

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • E.
    • South Africa
    • Rest of Middle East and Africa

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to industry leaders, consultants, and strategy professionals.

Our reports are single-point solutions for industries to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for client-specific problems with right methodology of research is the key to help enterprises reach right decision.

U.S. Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com  
Website: https://www.transparencymarketresearch.com